In the turbulent COVID-19 context, Humanitas Solutions has adapted technologies it developed after the 2010 earthquake in Haiti to help the health system counter the effects of the pandemic. Mitacs interns from five universities are helping to implement solutions to deal with the emerging second wave.
Simon Fraser University students collaborate with the Metlakatla Stewardship Society on a management program that equips the Metlakatla First Nation to make well-informed decisions on the cumulative effects of resource exploration within their territory
Mitacs interns have teamed up with iMD Research to create a Bluetooth bracelet that uses artificial intelligence to predict the likelihood that a COVID-19 patient will need to be hospitalized based on their vital signs.
Researchers based at the University of British Columbia work with Indigenous partners to create an app to help translate children’s stories published in global sites into Indigenous languages of Mexico.
University of Regina researchers team up with residents of Île-à-la-Crosse, Saskatchewan, on a platform to support enduring solutions to the COVID-19 crisis. The initiative has the potential to expand beyond the region and address other challenges.
In many remote locations, access to medical supplies, which can make the difference between a speedy recovery and death, can be limited because of their sensitivity to temperature variations during transport.
Research team from the University of Guelph is helping an Ontario-based company to provide a health care solution, innovate, and diversify their business by turning UV technology for cleaning fresh produce into a mask decontaminant.
When a radio repeater fails, police and fire fighters can’t communicate. Factories stop. To reduce outages, a multidisciplinary research team combines Industrial Internet of Things, data science, and artificial intelligence.
One company that’s addressing the need for a vaccine is Medicago, a biopharmaceutical company that’s using a new manufacturing technology based on Plants and Virus-like Particles (VLP). Medicago is creating a vaccine that has the potential to promote antibody production, and unlike cell culture systems, plant systems do not require complicated growth or storage conditions.
A collaborative research project supported by Mitacs is contributing to enhance St.Amant’s community transitions by documenting and evaluating their impact on health and quality of life of persons with severe intellectual and developmental disabilities.